GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PRA Health Sciences Inc (NAS:PRAH) » Definitions » Other Income (Minority Interest)

PRA Health Sciences (PRA Health Sciences) Other Income (Minority Interest) : $0 Mil (TTM As of Mar. 2021)


View and export this data going back to 2014. Start your Free Trial

What is PRA Health Sciences Other Income (Minority Interest)?

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary. PRA Health Sciences's Other Income (Minority Interest) for the three months ended in Mar. 2021 was $0 Mil. Its Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Mar. 2021 was $0 Mil.


PRA Health Sciences Other Income (Minority Interest) Historical Data

The historical data trend for PRA Health Sciences's Other Income (Minority Interest) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PRA Health Sciences Other Income (Minority Interest) Chart

PRA Health Sciences Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Other Income (Minority Interest)
Get a 7-Day Free Trial Premium Member Only - -0.37 -0.55 -0.10 -

PRA Health Sciences Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
Other Income (Minority Interest) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

PRA Health Sciences Other Income (Minority Interest) Calculation

Other Income (Minority Interest) represents par value or stated value of the subsidiary stock not owned by the parent company plus the minority interest's equity in the surplus of the subsidiary.

Other Income (Minority Interest) for the trailing twelve months (TTM) ended in Mar. 2021 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PRA Health Sciences  (NAS:PRAH) Other Income (Minority Interest) Explanation

Minority interest is a significant but non-controlling ownership of less than 50% of a company's voting shares by either an investor or another company. It is reported on the consolidated income statement as a share of profit belonging to minority shareholders.


PRA Health Sciences (PRA Health Sciences) Business Description

Traded in Other Exchanges
N/A
Address
4130 ParkLake Avenue, Suite 400, Raleigh, NC, USA, 27612
PRA Health Sciences is a global contract research organization that provides drug development and clinical trial services to pharmaceutical and biotechnology firms. Its services run from early- to late-stage clinical trial outsourcing with varying levels of support, including one-off specialized staffing services to strategic partnerships where PRA handles nearly all aspects of the trial. In 2017, PRA acquired Symphony Health, a healthcare data and analytics provider. PRA's competitor, Icon, announced it will acquire PRA for $12 billion, which is scheduled to close in third-quarter 2021.
Executives
Michael J. Bonello officer: EVP & CFO 4130 PARKLAKE AVENUE, SUITE 400, RALEIGH NY 27612
Shannon Colin director, officer: President & CEO PRA INTERNATIONAL 12120 SUNSET HILLS ROAD, SUITE 600 RESTON VA 20190
Christopher L Gaenzle officer: EVP, CAO & General Counsel C/O INC RESEARCH HOLDINGS, INC., 3201 BEECHLEAF COURT, SUITE 600, RALEIGH NC 27604
Glen D. Stettin director C/O EXPRESS SCRIPTS HOLDING COMPANY, ONE EXPRESS WAY, ST. LOUIS MO 63121
Alexander George Dickinson director 31542 CATALINA AVE LAGUNA BEACH CA 92651
Jeffrey T Barber director 6501 WESTON PARKWAY, SUITE 200 CARY NC 27513
Matthew P. Young director C/O JAZZ PHARMACEUTICALS PLC, 5TH FL, WATERLOO EXCHANGE, WATERLOO RD, DUBLIN L2 4 L2
Linda S Grais director 86 ALEJANDRA AVE, ATHERTON CA 94027
James C Momtazee director 2884 SAND HILL ROAD, SUITE 100, MENLO PARK CA 94025
George R Roberts 10 percent owner C/O KOHLBERG KRAVIS ROBERTS & CO. L.P., 2800 SAND HILL ROAD, MENLO PARK CA 94025
Kkr Pra Investors Gp Ii Llc 10 percent owner 9 WEST 57TH STREET, SUITE 4200 NEW YORK NY 10019
Kkr Pra Investors L.p. 10 percent owner 9 WEST 57TH STREET, SUITE 4200 NEW YORK NY 10019
Kkr Pra Investors Gp Llc 10 percent owner 9 WEST 57TH STREET, SUITE 4200 NEW YORK NY 10019
Kkr North America Xi Ltd 10 percent owner KOHLBERG KRAVIS ROBERTS & CO. L.P., 9 WEST 57TH STREET, SUITE 4200, NEW YORK NY 10019
Kkr North America Fund Xi L.p. 10 percent owner C/O KOHLBERG KRAVIS ROBERTS & CO. L.P., 30 HUDSON YARDS, NEW YORK NY 10001

PRA Health Sciences (PRA Health Sciences) Headlines

From GuruFocus

PRA Health Sciences to Report Third Quarter 2020 Earnings

By Marketwired Marketwired 10-08-2020

PRA Health Sciences to Report Third Quarter 2020 Earnings

By GlobeNewswire GlobeNewswire 10-07-2020